Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05374876
What this trial is testing

Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy

Who this might be right for
Adenocarcinoma of Pancreas
HonorHealth Research Institute 49
Large-scale testing (Phase 3)Study completedNCT00033735
What this trial is testing

Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eisai Inc. 158
Testing effectiveness (Phase 2)Study completedNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Study completedNCT00203892
What this trial is testing

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Chicago 23
Not applicableLooking for participantsNCT07148830
What this trial is testing

Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Minia University 100
Testing effectiveness (Phase 2)Study completedNCT01369420
What this trial is testing

NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Angiodynamics, Inc. 10
Early research (Phase 1)Ended earlyNCT02268825
What this trial is testing

Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

Who this might be right for
Advanced GI Cancer
University of Utah 39
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Early research (Phase 1)Study completedNCT01166490
What this trial is testing

Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Who this might be right for
Gastric NeoplasmsPancreatic Neoplasms
Seagen Inc. 51
Not applicableStudy completedNCT05048810
What this trial is testing

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nanjing First Hospital, Nanjing Medical University 6
Early research (Phase 1)Looking for participantsNCT06867497
What this trial is testing

Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Boryung Pharmaceutical Co., Ltd 20
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Early research (Phase 1)Not Yet RecruitingNCT07829185
What this trial is testing

Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Oklahoma 30
Early research (Phase 1)Active Not RecruitingNCT04477343
What this trial is testing

Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
University of Rochester 20
Testing effectiveness (Phase 2)Study completedNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Not applicableStudy completedNCT04602026
What this trial is testing

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

Who this might be right for
Adult Liver CarcinomaGastric CarcinomaMalignant Solid Neoplasm+1 more
Ohio State University Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00335543
What this trial is testing

Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft 254
Early research (Phase 1)UnknownNCT03703089
What this trial is testing

Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Not applicableLooking for participantsNCT05630989
What this trial is testing

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, MD 80
Next Page